| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash used in investing activities | -15,460 | -20,712 |
| Proceeds from exercise of share options | 8,087 | 6,221 |
| Proceeds from issue of convertible senior notes | 0 | 0 |
| Payments for debt issuance costs | 0 | 0 |
| Net cash provided by financing activities | 8,087 | 6,221 |
| Increase in cash and cash equivalents | 14,570 | 11,908 |
| Effect of exchange rate changes on cash | 28,112 | - |
| Cash and cash equivalents at beginning of period | 455,731 | - |
| Cash and cash equivalents at end of period | 498,413 | - |
Immunocore Holdings plc (IMCR)
Immunocore Holdings plc (IMCR)